FlorianPThomasMD, MA, PhD, MS
Neurology • Hackensack, NJNeuroimmunology/Multiple Sclerosis, Neuromuscular Medicine, Spinal Disorder
Chair, Neuroscience Institute & Dept. of Neurology; Director, Hereditary Neuropathy Center; Co-Director, Center for Memory Loss & Brain Health & ALS Center, Hackensack University Medical Center. Professor & Founding Chair, Dept. of Neurology, & Associate Dean of Faculty, Hackensack Meridian School of Medicine. Professor Emeritus, Department of Neurology, St. Louis University School of Medicine
Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Prospect Ave
# Neurosci
Hackensack, NJ 07601Phone+1 551-996-8100Fax+1 551-996-4140
Education & Training
St. Louis UniversityMS, Health Outcomes Research & Evaluation Sciences, 2011 - 2015- McGill UniversityPhD, Molecular Biology, 1991 - 1995
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 1984 - 1987
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1983 - 1984- University of BonnMA, Psychology, 1977 - 1983
University of Bonn Faculty of MedicineClass of 1982
Certifications & Licensure
MI State Medical License 1984 - 2027
MO State Medical License 1995 - 2026
NJ State Medical License 2016 - 2025- American Board of Physical Medicine and Rehabilitation Spinal Cord Injury Medicine
- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesNeural Repair and Rehabilitation
Clinical Trials
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
- Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Start of enrollment: 2017 Mar 07
Publications & Presentations
PubMed
- Clinical characteristics of pediatric and adult myelin oligodendrocyte antibody-associated disease (MOGAD): A single-center study in the Northeast.Allison M Brown, Aishwarya Sridhar, Felicia Gliksman, Florian P Thomas, Krupa Shah Pandey
Multiple Sclerosis and Related Disorders. 2024-12-01 - Embracing Inclusion, Diversity, Equity and Access (IDEA): Cultivating understanding internally to foster external change.Jeffrey P Jaramillo, Sigmund Hough, Jillian Walker, Trisha Hicks, Florian P Thomas
The Journal of Spinal Cord Medicine. 2024-11-22 - Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.Shahram Attarian, Peter Young, Thomas H Brannagan, David Adams, Philip Van Damme
Orphanet Journal of Rare Diseases. 2024-04-01
Press Mentions
The Hackensack University Medical Center Neuroscience Institute Delivers Inclusive Care for LGBTQ+ PatientsOctober 5th, 2021- Focused Ultrasound Breakthroughs from the Summer of 2021September 20th, 2021
- Neuroscience Institute at Hackensack Meridian Hackensack University Medical Center Receives Grant from University of Pennsylvania and Hereditary Neuropathy Foundation to Study Charcot-Marie-Tooth DiseaseSeptember 8th, 2021
- Join now to see all
Other Languages
- German, French, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
